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ABSTRACT
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death
in the United States and is predicted to be the third leading cause of death worldwide
between 2020 and 2030. Smoking continues to be the primary cause of this disease,
which is associated with about 80% of all COPD deaths. 1,2,3,4 Signs and symptoms of
COPD can be debilitating; however pulmonary recovery positions may be taught to
improve breathing capabilities in impaired individuals. Literature suggests techniques for
pulmonary recovery may involve supporting the upper extremities, supporting the head,
and leaning forward. The purpose of the current study was to examine the effects of
pulmonary recovery positions on EMG activation of accessory muscles of respiration.
The goal was to clarify which recovery positions have the greatest activation of the
accessory muscles, Eleven healthy adults over the age of eighteen were recruited for this
study. Unilateral EMG surface electrodes were placed on the accessory muscles of
breathing which included upper trapezius (UT), sternocleidomastoid (SCM), pectoralis
major (clavicular head) (PM), serratus anterior (SA), and latissimus dorsi (LD). The
subjects were randomly assigned a series of four experimental positions which included:
a control position with hands at the sides (Position 1), standing with hands resting
overhead (Position 2), leaning forward with hands on knees (Position 3), and sitting with
forearms and hands supported by a table (Position 4). In each position, EMG activity
was collected during three separate trials of maximal inspiration and maximal expiration,
as well as minute ventilation (MV). Results indicated a significant increase in unilateral
EMG activity while in Positions 2 and 3. Results found an increase in MV in Positions 2
and 3 though these fmdings were not significant. Positions 2 and 3 have the greatest
possibility to recruit the accessory muscles of ventilation, therefore improving air
exchange with patients who suffer from COPD.
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CHAPTER I
INTRODUCTION

Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term used to
describe a variety of progressive lung diseases that impede airflow during various phases
of the breathing cycle. Two primary forms of COPD exist, emphysema and chronic
bronchitis, but diagnoses such as refractory (non"reversible) asthma and certain types of
bronchiectasis are also included. s Using spirometry, Global Initiative for Chronic
Obstructive Lung Disease (GOLD) has defined the values for diagnosis of COPD as
forced expiratory volume in 1 second (FEVI)/forced vital capacity (FVC) ratio < 0.7. 6
COPD's encompassing diseases are a leading cause of mortality. It is predicted that
between 2020 and 2030, this debilitating disease will become the third leading cause of
death worldwide. 2•3,4 COPD has a predicted occurrence rate estimated at 4-10%
universally and 37% in the United States. 7•S Chief prevalence is seen in smokers
especially those who have> 40 pack-years of smoking or are current smokers. Males and
people over the age of 45 with a dramatic increase in individuals older than 75 years of
age also show increased prevalence. 7•8 COPD is characterized by progressive dyspnea,
productive or non-productive cough, wheezing, and a feeling of tightness or fullness in
the chest. s Primary risk factors include long-term inhalation of irritants such as cigarette
smoke, occupational exposures such as dust, chemical agents, and fumes, and overall
inactivity. Typically, dyspnea is the first symptom to appear and correlates to
progressive decreases in activity. Dyspnea's contributing factors may include: secondary
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polycythemia, pulmonary hypertension, systemic inflammation, and skeletal muscle
dysfunction. Research suggests that a combination of these factors leads to diminished
quality of life, reduced exercise tolerance, increased risk of cardiovascular morbidity, and
greater risk of death. 3 Spirometry can be used to monitor regression rate of overall lung
function and, ultimately, decreases in quality of life that occur in patients with COPD.
Spirometry testing continues to gain clinical interest, particularly when
considering disease severity, functional ability, and lung capacities of those with COPD.

In any disease characterized by dyspnea, it should be noted that the FEVI is weakly
correlated with patients' ratings of dyspnea (r=0.29; 95% CI, 0.22 to 0.35).9 Spirometry
can also be used as an outcome measure of therapy, as well as for prognostic purposes.
Literature shows that spirometry lung volumes, specifically vital capacity, are reduced in
most patients with COPD compared to healthy individuals. 10 Spirometry results that
show progressively lower lung volumes directly correlate with increases in disease
severity. Studies show that physicians undemtilize spirometry for diagnosis and
progression of COPD, which leads to underestimation of disease severity and
diagnosis.II.1 2 Physicians properly trained in spirometry testing and interpretation have
been shown to increase the use of spirometry as a diagnostic tool, as well as improve
accuracy when determining level of severity of COPD.13
Limited diaphragmatic excursion in clients with COPD contributes to lower lung
volumes as identified through spirometry. The patients with COPD can utilize accessory
respiratory muscles to assist in breathing as a means of improving ventilation of air and
respiration of oxygen in the lungs. Some of the accessory muscles utilized for breathing
include; upper and middle trapezius, latissimus dorsi, pectoralis maj or, erector spinae,
2

internal and external obliques, intercostals, abdominals, and serratus anterior. 3 These
skeletal muscles playa vital role in providing the mechanical basis for respiration and
movement. However, skeletal muscle dysfunction is prevalent in all stages of COPD and
significantly influences symptoms, functional capacity, health-related quality of life,
health resource usage, and even mortality.4Electromyography (EMG) is a widely
accepted tool that uses electrical signals to assess muscular activity. This includes
activity of accessory respiratory muscles, which are often recruited in people suffering
from COPD. The use ofEMG displays acceptable reproducibility in patients with COPD
and healthy subjects. The EMG is sensitive enough to detect different breathing patterns
when inhaling increased inspiratory loads. 14 Thus, EMG is proven to be a reliable tool in
the detection and assessment of action potentials of respiratory muscle tissue.
Lomax et al. (20B) compared the EMG activity of accessory inspiratory muscles
of eight college swimmers after front crawl sprints. It was concluded that inspiratory
muscle fatigue affected the activity of latissimus dorsi during the sprints. IS Another study
looked at the effects of a physical therapy program on accessory inspiratory muscle
usage. After body posture realignment and respiratory training, the EMG recordings
indicated less effort of the accessory inspiratory muscles. 16 There are many factors that
have a potential effect on inspiratory muscle activity, but additional research is required
to conclude which muscles assist the most how to best recruit muscles that augment
ventilation.
In physical therapy, patients with COPD are often taught techniques to increase
lung capacity, free airways of sputum, conserve energy, and recover from taxing
activities relative to the patient's health status. Suggested positions for pulmonary
3

recovery include: supporting the upper extremities, supporting the head, and leaning
forward. Patients should be encouraged to assume a recovery position that allows for
prompt primary and secondary respiratory muscle recovery. In one such study, it was
shown that patients with COPD who utilize a forward leaning trunk position with neutral
head and neck had relief of dyspnea and decreased airway obstruction at a faster rate than
the control group. As a result, pulmonary function was improved. I7 It was also noted
that forward leaning with arm support and forward leaning with head and arm support
produced increased activity of inspiratory accessory muscles during inspiration compared
to neutral sitting positions for patients with COPD.I7 In another study conducted by
Romei, et.al (2010), using Opto-Electronic Plethysmography, it was found that rib cage
expansion, tidal volume, and minute ventilation were greatest in a seated position without
back support, and that these three values decreased with the use of back support and
continued to decrease as the angle of inclination from supine decreased. Body position
had a significant effect on rib cage and abdominal kinematics during quiet breathing.
This demonstrates that body position can effect chest volume and ventilatory volumes. IS
There still remains limited research that compares these different positions and their
effects on accessory respiratory muscle activation in relation to lung capacity.

In another study, EMG activity of the sternocleidomastoid, scalenes, and upper
trapezius was recorded in patients with severe COPD in seated and supine positions while
breathing at rest. It was found that little to no activity was seen in the stated muscles. 19
Other studies support this evidence; the forward leaning posture is associated with a
significant reduction in EMG activity of the scalene and sternocleidomastoid muscles.
This is most likely due to an increase in trans diaphragmatic pressure, inspiratory muscle
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pressure, and significant improvement in thoracoabdominal movement. 20 However, when
dyspnea and inspiratory efforts are increased on exertion, EMG activity of the scalene
muscles also increase. 2 ! Panka et. al. (2010) reported there is an increase in
sternocleidomastoid activity with unsupported arm elevation while performing ADL'S.22
During the use of unsupported arm elevation, two factors became determinants of the
altered respiratory pattern: lung hyperinflation and, to a smaller degree, diaphragm
reserve strength. Due to dynamic hyperinflation during inspiration, the respiratory
muscles are placed in an unfavorable position on the length-tension curve, reducing the
force generating capacity.22 During arm elevation at rest, there was a significant decrease
in vital capacity and a small decrease in functional residual capacity.!O
The aim of the current study is to investigate the effects of recovery positions on
the EMG activation of accessory muscles of respiration and dynamic pulmonary function
using a hand-held spirometer. The data from this study may be utilized to determine
which recovery positions may be the most effective for activating muscles of expiration
for patients with COPD.
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CHAPTER II

METHODS

This project was reviewed and approved by the University of North Dakota Institutional Review
Board (IRB-201505-361) prior to initiation of the study (See Appendix).
Subjects

Subjects were recruited from a sample of convenience in the Department of Physical
Therapy at the University of North Dakota. The subjects participating in this study were
obtained on a voluntary basis and all subjects completed an informed consent form prior to
participation (See Appendix). The inclusion criteria included health adults over the age of 18.
The exclusion criteria included breathing difficulty with physical activity, injuries to the chest or
back in the past three months, and allergic reactions to adhesives. Each subject completed a
subject questionnaire and data collection form. The subjects attended one session of
approximately one hour of testing in the Department of Physical Therapy on the University of
North Dakota campus in the School of Medicine and Health Sciences. The testing was
completed in a private research room for the confidentiality and privacy of the subjects. Subjects
did not receive compensation for participating in this study.
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Instrumentation
Instrumentation for this study included electromyography (EMG) hardware and
software. The EMG data collection was performed using self-adhesive pre-gelled EMG
surface electrodes. These electrodes were placed over standard electrode sites only on
the right side of each test subject. Muscle activity was collected unilaterally on the
following muscles: upper trapezius(UT), stemocleidomastoid(SCM), pectoralis major
(clavicular head)(pM), serratus anterior(SA), and latissimus dorsi(LD). The EMG data
was collected using the Noraxon MyoResearch XP software and the TeloMyo 2400 G2
telemetry system. Data analysis for the EMG data was performed on a laptop computer
(Dell Technologies, Inc) using Noraxon MyoResearchXP software (Noraxon, USA,
Scottsdale, AZ).

Procedure
Prior to the initiation of the study, the EMG equipment was set up and tested by
the researchers to ensure proper signal transmission and reception. The subj ects were
tested independently in the Department of Physical Therapy located at the University of
North Dakota School of Medicine and Health Sciences. The purpose and procedure for
the study was explained to the participants prior to each participant signing a statement of
informed consent, completing the intake survey, and initiation of data collection.
The collection of EMG data required electrode site preparation, electrode
placement, connection of hardware, and testing of the equipment. The electrode site
preparation was performed in a standardized fashion including removal of excess hair
from the electrode site with an electric razor, gently rubbing the skin surface with 400 grit
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sandpaper, and cleaning the area wIth isopropyl alcohol. Electrode placement was
determined by using standard electrode placement recommendations. (Criswell 2011 )
Standard silver/silver chloride electrodes were placed in a bipolar configuration at the
appropriate sites using an inter-electrode distance of approximately 1.5 cm. The Noraxon
skin impedance analyzer was used to assess electrode placement and ensure low
«50kOm) impedance (Noraxon, USA, Scottsdale AZ). The electrodes were connected
to the TeleMyo 2400 G2 transmitter (Figure 1). The EMG signals were transmitted to the
TeleMyo 2400 G2 receiver and stored on a laptop computer (Dell Technologies, Inc.).
The raw EMG data was later analyzed for intensity of activation of the muscles using the
MyoResearch XP software. (Noraxon, USA, Scottsdale AZ).

----------- ------------------------------------- ----- +

accessory muscles
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1.

2.

3.

4.

Figure 2: Pulmonary recovery positions of, 1. Hands at sides, 2. Hands on head, 3. Hands on
lmees, and 4. Anns su ported by table

Initially the subjects perfonned a mild muscle contraction to detennine correct
electrode placement. The subjects were instructed in performing isometric maximal
voluntary contractions (MVCs) for a duration of 5 seconds in the following positions.
For UT, the patient used both hands to pull a cloth belt wrapped under the feet while
standing upright. For the SCM, the researcher placed a hand on the forehead of the
subject and the subject pushed into the hand. For the LD, the subject perfonned an
isometric seated row using a cloth belt secured to the hi-low table. The PM and SA
isometric MVC were tested by wrapping a cloth belt around the back of the chair then
pushing forward like a bench press.
The subjects were randomly assigned a series offour different experimental
positions including the control position of standing with hands at sides. Experimental
positions included: standing with hands overhead, leaning forward with hands on knees,
and sitting with foreanns and hands supported by a table (See Figure 2). In each position,
EMG activity was collected during three separate trials of maximal inspiration and
9

maximal expiration using a hand-held spirometer (Jaeger SpiroPro+® SensorMedics
Corp. Yorba Linda CA). The ventilation volumes retained for further analysis included
forced expiratory volume in one second (FEYl), forced vital capacity (FYC), and minute
ventilation (MY). During spirometry, the subjects utilized a nose clip to force all air
through the mouth opening. To obtain FEYl, and FYC, one of the researchers held the
spirometer at a comfortable position for the subject. The subject then performed a slow
deep expiration followed by a forceful inspiration, forceful expiration, and completed
with a final forceful inspiration. For minute ventilation, the subject was asked to inhale
and exhale as deeply and controlled as possible for 15 seconds. The MY results were
extrapolated by multiplying the volume by four in the data collection. Subjects
performed three maximal breaths and two minute ventilation activities for each position.
At least one minute of rest separated each of the trials. Following the completion of data
collection in all experimental positions, the electrodes were removed from the subj ects
followed by cleaning the areas with isopropyl alcohol to remove any remaining gel and
adhesive.
Data Analysis
Raw EMG data was analyzed using the Noraxon Myoresearch Software Program.
The EMG data was normalized to the maximal voluntary contractions, rectified, and
smoothed using the root mean square (RMS) option set at 50 millisecond collection
frames. Composite data is presented as average!SD for all subjects within an
experimental condition.
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Statistical Analysis
Data are presented as mean±Standard deviation. A one-way, repeated measures
analysis of variance was utilized to determine differences between the experimental trials
for each individual muscle (alpha:'SO.05). Mauchley's Test of Sphericity was performed
followed by the ANOYA. When the data did not meet the assumption of sphericity, a
Lower Bound correction was utilized to determine the critical F-value for the ANOYA.
Pairwise comparisons were reviewed where the critical F-value was found to be
statistically significant (p<O.05).

11

CHAPTER III
RESULTS
Eleven subjects between the ages of22 and 28 participated in the study including
seven females and four males (Table 1). The data and analysis are combined for
reporting purposes. The average age ofthe subjects was 25±2 years. The average height
of the subjects was 66.4±3.2 inches while the average weight was 160±29 pounds.

Table 1. SUb.iect Demo2raphics
N
Female
7
Male
4
11
Total

Age
25+2
24+2
25+2

Height (in)
64.5+2.4
69.6+0.8
66.4+3.2

Wei2ht (Ibs.)
147.8+26
182+20
160+29

A one-way repeated measures ANOYA was calculated comparing unilateral
EMG activity of the UT, SCM, PM, SA, and LD of 11 subjects in four different
positions: arms at sides (control), hands on head, hands on knees, and arms supported on
table (Figure 2:1-4). When recording EMG activity during maximal inspiration (Table
2), there were significant differences in unilateral EMG activity in the UT, SCM, PM,
and SA. No significant differences were found in the LD in any of the four positions.
The UT had a significant increase in EMG activity in Position 2 compared to Positions
1,3, and 4. The SCM had a significant increase in EMG activity in Position 3 when
compared to Positions 2 and 4. The SCM EMG activity was significantly lower in
Position 4 as compared to the other three positions. The PM had a significant increase in
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EMG activity in Position 3 when compared to the other three positions. The SA had a
significant increase in EMG activity in Position 1 as compared to Positions 2 and 3, and
Position 3 had a significant increase in EMG activity when compared to Position 4.
'Table 2. Electromyographic (EMG) activity of the accessory muscles of ventilation during differe"irt-pulmonary recovery positions during inspiration.
F value
Muscle
Hands on
Hands on
Arms
Hands at
Knees
supported
Side
Head
on table
(M±SD)
(M±SD)
(M±SD)
(M+SD)
F (1,10)-11.553, p<.007,
5.0±2.7
UT
5.1±2.7
25.0±20.2
5.3±4.3
11.'=.536, power=.864
F
(1,10)=12.099, p<.006,
47.7±30.8
33.0±18.1
16.2±8.1
SCM
42.6±26.3
11.'=.547, power=.879
F(3,30)-3.862, p<.019,
12.7±8.6
19.8±11.9
12.5±10.7
PM
12.7±13.1
11.'=.729, power=.769
30.4±22.3
F(3,30)=3.586, p<.02n
25.1±15.0
19.5±17.1
SA
16.2±11.3
11.'=.264, power=.734
NSD, power=. 10 1
16.4+9.8
14.5+ 14.8
13.2+9.4
LD
12.5+ 11.7
UT = Upper Trapezius, SCM = Sternocleidomastoid, PM = Pectoralis Major, SA = Serratus
Anterior, LD = Latissimus Dorsi
-.-

During the expiration phases of FVC (Table 3), we found significant differences in
EMG activity with the UT, SCM, PM, and LD. For the UT, there was higher EMG
activity found in Position 2 compared to the other positions tested. For the SCM, we
found that Position 2 provided the highest EMG activity compared to the others. The PM
showed significant differences in Position 3 and 4 compared to Positions 1 and 2. For the
LD, we found significantly higher EMG activity in Position 3 compared to the others.
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Table 3. Electromyographic (EMG) activity of the accessory muscles of ventilation during
different pulmonary recovery positions during expiration.
Arms
Muscle Hands at
Hands on Hands on
Fvalue
supported
Side
Head
Knees
on table
(M±SD)
(M±SD)
(M±SD)
(M+SD)
F(1,10)-11.030, p-.OO8,
18.4±15.2
3.8±2.6
6.0±6.9
UT
3.3±1.7
11.'=.524, power=.848
F(1,10)=12.330, p=.OO6,
SCM
14.1±8.0
11.8±5.5
6.6±4.6
13.8±7.4
11.'=.552, power=.885
F(1,10)=8.609,p-.OI5,
12.5±6.4
5.3±3.8
PM
7.8±5.1
8.4±5.1
11.'= .463,power=.753
NSD ,power-.090
18.4
14.8+9.8
28.8+
SA
16.4+11.2 26.3+19.3
-F(3,30)-5.653,p-.OO3,
24.1±16.0
10.2±7.4
LD
15.0±13.0
11.3±6.5
tt.361,power=.914
UT = Upper Trapezius, SCM = Sternocleidomastoid, PM = Pectoralis Major, SA Serratus Anterior, LD = Latissimus Dorsi
-When comparing unilateral EMG muscle activity in each position during minute
ventilation (Table 4), the UT showed significantly higher muscle activity in position 2
when compared to Positions 1,3, and 4. The SCM showed no differences between the
positions. Comparing the positions of the PM, significantly higher activity in Position 3
was observed compared to 1 and 4. For the SA, significantly higher activity was
observed in Position 2 compared to Positions 1 and 4, and significantly higher activity in
Position 3 compared to 1 and 4. For the LD, we observed no significant difference across
positions.
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Table 4. Electromyographic (EMG) activity of the accessory muscles ofveutilation during
different pulmonary recovery positions durin!! minute ventilation.
Muscle Hands at
Hands on
Hands on
Arms
Fvalue
Side
Head
Knees
supported
ou table
(M±SD)
(M±SD)
(M±SD)
(M+SD)
F{l,7)-18.687, p-.003
UT
3.14±1.57
12.59±6.80
3.22±2.21
2.63±1.37
rr= .727, !lower = .957
SCM
16.31±11.69 15.24±8.09
11.55±7.52
12.97±8,43 F(3,21)= 1.13, p=.359
re= .139, power = .260
F(3,21) = 6.638,
8.21±5,45
10.78±5.32
PM
5.69±3.61
6.05±5.21
p=.003 rr= ,487,
power = .941
F{l,7)
- 7,493, p-.029
19.24±15.60 21.04±16.13
SA
8.58±5.94
5.67±4.30
2
11. = .517, power = .653
F(1,7) - 3.237, pLD
14.81±16.60 8.09±10,45
8.88±10.65
9.75±8.68
.115 11.2= .316, power
= .343
UT = Upper Trapezius, SCM = Sternocleidomastoid, PM = Pectoralis Major, SA =
Serratus Anterior, LD = Latissimus Dorsi

A one-way repeated measures ANOVA was calculated comparing FVC, FEVl,
and MV average values of 11 subjects in the four different positions (See Figure 1). No
significant effect was observed for the pulmonary ventilation values. (See Table 5).
Table 5. Pulmonary volumes observed during spirometry in four different pulmonary
recovery positious.
F value
Pulmonary Hands at
Hands on Arms
Hands on
Knees
supported
Measure
Side
Head
on table
(M±SD)
(M±SD)
(M±SD)
(M+SD)
NSD power = .312
3.87 + .74
3.99 + .79
4.06 + .89
FVC
3.90 + .80
3.54 ± .76
3.64 ± .83
3.71 ± .81 F(3,30) =3.284 p=.034
FEV!
3.54 ± .79
rt2= .247 power= .692
NSD, power= .323
9.92±4.67
MY
12.90 ±
10.00 ± 5.98 11.55 ± 9.34
7.73
FVC = Forced Vital Capacity, FEVl = Forced Expiratory Volume, MV = Minute Ventilation
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CHAPTER IV

DISCUSSION
The aim of this study was to examine the effects of various pulmonary recovery
positions on EMG activity of the accessory muscles of respiration using a handheld
spirometer. The sample subjects tested were healthy, young adults. Data was applied
and related to COPD to determine which recovery position may be the most effective for
dyspnea associated with reduced pulmonary ventilation. Findings of this study
demonstrate that different recovery positions do not provide a significant difference in
MV and FVC lung volumes. Bhatt et al. (2009) researched spirometry, maximal
inspiratory and expiratory measures, and diaphragmatic excursion during tidal volume
and vital capacity. The specific positions tested were sitting, supine, and tripod, which
consisted of sitting forward with hands supported on the knees. Although the tripod
position is not identical to any of the four positions in the current study, it combines two
of the current study's testing positions, sitting with arms on table (Position 4) and hands
on knees (Position 3). It was found that there is no difference in tripod position
compared to sitting and supine positions measuring spirometry, maximal inspiratory and
expiratory pressures and diaphragmatic excursion. 23 Therefore, the results of the current
study parallel previous research in concluding that there are insignificant differences in
resting respiratory volumes in recovery positions compared to a control position.
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The positions have shown changes in how respiratory muscles are utilized. The
results of the current study concluded that there was a significantly higher level of
unilateral EMG activity during inspiration when the hands were placed over head
(Position 2) for the UT, SCM, and SA. There was also a significant difference in EMG
activity shown with the hands on knees (Position 3) for the PM, SCM, and SA.
In a review article, O'Donnell et al. (2015) identified the abnormalities of
pulmonary gas exchange, respiratory mechanics, and compensatory adaptations of the
respiratory system that develop in response to increasing physiological impairment, such
as with mild COPD. It was concluded that patients with mild COPD had an increased
contractile respiratory muscle effort.24 This increased effort is used to assist in effective
alveolar ventilation to counteract the body's decreased ability to exchange gases within
the lungs. Since COPD causes an increase in accessory respiratory muscle activity, we
aim to understand how body positions could assist with respiratory muscle activation, as
well as overall ventilation. Finding a pulmonary recovery position that provides
increased accessory muscle activation and increased ventilation volume should provide a
more efficient means of relieving dyspnea in patients with COPD status. The current
study produced results that indicate standing with hands on head (Position 2) and
standing with hands on knees (Position 3) are two positions that significantly increase
activation of respiratory accessory muscles. Notably, the hands on head (Positon 2) and
hands on knees (Position 3) revealed trends of increased MV volumes, although the
findings were not significant.
Puhnonary recovery positions used by patients with COPD allow accessory
muscles of respiration to be placed in a more favorable position to facilitate increased
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muscle force production. However, these respiratory recovery positions may serve
another purpose. In a study conducted by Gosselink et al.(2004), a rehabilitation program
was utilized for COPD patients. It consisted of breathing techniques, pursed lip
breathing, forward leaning, active expiration, and inspiratory muscle training. The
forward leaning posture showed an increase in intra-abdominal pressure, which provides
support for the diaphragm. This forward leaning posture also showed decreased EMG
activity of the scalene and SCM.25 In the current study, Positions 3 and 4 both include
forward leaning. These positions displayed decreased SCM muscle activity in
comparison to Positions 1 and 2, which assume more of an upright position along with an
increase in SCM activity. Thus, this decrease in activity of accessory musculature in
Positions 3 and 4 in combination with similar fmdings in FYC and FEY! values in all
four positions show that there are other means of obtaining increased ventilation volumes
than accessory muscle activity alone. Another study measured multiple respiratory
muscle electromyograms, gastric, esophageal, and trans diaphragmatic pressures, and
thoracoabdominal diameters in the supine, standing, erect seated, and forward leaning
(seated) positions during quiet breathing. It was found that patients in the forward
leaning position had a profound relief of dyspnea as compared to the other positions.
Accessory inspiratory muscle EMG activity was augmented to a significantly greater
degree on assuming the standing and seated postures when compared to patients who did
not experience postural relief. Overall, this was attributed to increased efficiency of the
diaphragm because of the improved length-tension state, and increased activity of
accessory muscles of respiration. It can also be noted that FEYI and FYC values were
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not significantly different across positions, suggesting recovery positions decrease
dyspnea without volume changes in single breath activities such as FEV! and FVC. 26

In a study by Gerling et al. (2013), the LD muscle's ability to generate force was
analyzed. It was found that, despite the LD muscle's large cross-sectional area, its lack
of sarcomere distribution in parallel provides only moderate force
production.27 However, this large cross-sectional area can provide accessory breathing
capabilities with the arms extended and, with its attachment to the trunk, moderate
expansion of the chest for breathing. Although the current study did not find a significant
change in EMG activity across positions, there was an overall increase in EMG activity
ofLD in the hands on knees position (Position 3). This position allows upper extremity
weight bearing with the arms extended to allow chest movement supported by LD.
The results of the current study are similar in results to previous studies published.
The small sample size consisted of individuals who were moderately active and healthy.
Future studies should include much larger sample sizes which will help in the
generalizability of the results. Additionally, a more diverse sample size, including
patients with obstructive or restrictive pulmonary diseases, would be helpful since we
cannot reproduce the effects of the disease accurately with healthy subjects. Excluded
data points in the spirometry data indicated by a reduction of three participants, also
affected.our already small sample size further reducing our generalizability. The
excluded data points could be a result of interference of electrodes or the wires attached
to them, utilizing newer wireless electrodes in the future could eliminate this problem.
With our large standard deviation, it should be noted that further studies should include
more practice for spirometry data collection. Performing spirometry is a skill which
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requires multiple practice sessions. The variances in minute ventilation data may be
improved with consistent and standardized instructions along with different equipment.
In order to accommodate the MV data collection we only had subjects perform for 15
seconds and extrapolated the data to ease the performance. This may have affected our
data collection, and should be examined further. Follow up studies could also include
relevance to athletes including exercise before and after data collection.

Accessory Muscle Use During Inspiration
60

50
>- 40

os;

.':;j"

30

\!J

::;;
L.W

20

10

o
RUT

RSCM

RPM

R LD

R SA

Accessory Muscle Tested

• pas 1 II pas 2

III

pes 3 • pas 4

:---~-:--.

...

.

.....

Figure 3. Accessory muscle use during inspiration in four different test positions.
'1=significantly different from all other muscle activity at p:O:O.05. *= significantly
different from positions without the same symbol at p:O:O.05.
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CHAPTER V
CONCLUSION

This study shows that there is an increase in EMG activity for accessory muscles of
breathing with the hands on head when standing (position 2) and the hands on knees
(position 3). We found no significant difference in MV between the positions, though the
overall trend also favored positions 2 and 3. These positions may provide more effective
pulmonary ventilation volumes for patients with COPD, despite the results shown on
healthy individuals.
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recovery. The purpose of this study is to assess accessory muscle activity using electromyography (EMG)
and size of breath volume in different recovery positions.
II. Protocol Description

Please provide a thorough description of the procedures to be nsed by addressing the instrnctions under each of the following
categories.
1. Subj eet Selection.
a) Describe recruitment procedures (i.e., how subjects will be recruited, who will recruit them, where and when they will be
recruited and for how long) and include copies of any advertisements, fliers, etc., that will be used to recruit subjects.

Subjects will be recruited from the UND professional physical therapy classes. A flier (see attached)
will be displayed in the department during the summer 2015 and fall 20 IS semesters. The principle
investigator will announce the posting of the flier to students enrolled in the professional program.
b) Describe your subject selection procedures and criteria, paying special attention to tbe rationale fur including subjects
from any of the categories listed in the "Subject Classification" section above.

Subjects must be apparently healthy, 18 years of age, free of pulmonary disease, and no recent
injuries or conditions affecting the ability to breath or assume the experiments! positions. The use of
UND students in the professional physical therapy program reflects a sample of convenience.
c) Describe your exclusionary criteria and provide a rationale for excluding subject categories.

Under the age of 18 due to the inability to provide their own consent (minor). Subjects with
pulmonary disease or recent injuries or conditions affecting the ability to breath or assume
experimental positions are excluded because the study is expected to challenge the pulmonary system
during assessment ofthe volume of breathing with a spirometer. Additionally, injuries or conditions
affecting the ability to breath or assume the testing positions could produce undue discomfort for the
subject. The EMG electrodes utilize a tape-like adhesive for adherence to the skin and therefore
individuals with tape allergies will be excluded. Therefore, apparently healthy individuals over the
age of IS will be utilized for the study.
d) Describe the estimated number of subjects that will participate and the rationale for nsing that number of subjects.

It is estimated that 30 subjects will be recruited into the study. Each subject will serve as their own
control in the different breathing recovery positions. The 30 subjects are expected to provide a
normative distribution ofEMG and pulmonary function testing for healthy individuals. At the same
time, this number of subjects should provide the statistical power needed to identify significant
differences in EMG activity or lung volumes due to the different recovery positions.
e) SpecitY the potential for valid results. If you have used a power analysis to determine the number of subjects, describe
your method.

A statistical power analysis was not performed. HoweVer, in previous studies with EMG we have
observed 20-30 subjects provides adequate data to determine effectiveness of position or movement
changes on the muscles being studied.
2. Description ofMethodoIogy.
a) Describe the procedures nsed to obtain informed consent.

The principle investigator will announce the availability of the study to students in the professional
program. A flyer will be used to provide additioual information. Potential participants will be
provided with an overview of the purpose, study design, risks and results/outcomes of the study.
Each subject will be informed of the potential for adverse effects. Subjects will be provided with the
written consent form. Time will be allowed for any potential questions or concems. Piror to the
initiation of subject participation, each subject must provide verbal and written consent (see consent
form)
b) Describe where the research will be conducted. Document the resources and facilities to be used to carry out the proposed
research. Please note staffIng, funding, and space available to conduct this research.

The research will be conducted in the Department of Physical Therapy in the School of Medicine &
Health Sciences at the University of North Dakota. The department bas both electromyography
(EMG) software and hardware available for this project. The Noraxon Telemyo 2400 unit for EMG
data collection and analysis is available within the department. In addition, the department has a
SpiroPro (SensorMedics Corp, Yorba Linda CA) spirometer to obtain breathing volumes. The

principle investigator has experience in utilizing both pieces of equipment and software. The UND
PT department will provide the EMG electrodes and spirometer mouthpieces as needed.
c) Indicate who wlll carry out the research procedures.

The principle investigator, Dr. David Reiling, will perform subject consent and oversee all aspects of
the research project. Students in the professional physical therapy program (Joel Kramer, Kelsey
Meyer, Eric Nefstead, and Daniel Vilaubi) will assist with subject recruitment, intervention (data
collection) and data analysis. Dr. Reiling has training and experience using both the EMG system and
SpiroPro spirometer. Joel Kramer, Kelsey Meyer, Eric Nefstead, and Daniel Vilaubi have undergone
training on the EMG system and will obtain proficiency with the SpiroPro spirometer prior to
initiation of the study.
d) Briefly describe the procedures and techniques to be used and the amount of time that is required by the snbjects to
complete them.

Subjects will initially be fit with pre-gelled, self-adhesive surface electrodes placed over the motor
points of the relevant muscles. The electrodes collect underlying electrical activity within the
subject's muscles but do not provide any electrical shock or current to the subject. The muscles to be
monitored include upper trapezius, sternocleidomastoid, latissimus dorsi, pectoralis major, and
serratus anterior (See attached diagram). The subjects will be asked to wear tank tops to facilitate
access to the muscles and protect modesty. Prior to electrode placement, the skin will be prepared in
a standardized fashion and skin impedance will be measured to ensure adequate electrical conduction
at each site. Preparation of the skin includes removing excess hair from the electrode site with an
electric clipper and wiping the skin surface lightly with 400 grit sandpaper followed by wiping the
area with isopropyl alcohol wipes. The electrodes will be cOlUlected to a transmitter which will be
placed in a belt around the subject's waist. The EMG signals Will be transmitted to a receiver and
then to a computer. Raw EMG data will be obtained for analysis. Breathing volumes will be
assessed using the SpiroPro spirometer. Nose clips will be placed on the subjects nose to assure
accurate breathing volume through the spirometer. Subjects will place the spirometer mouthpiece
into the mouth and breath deeply for 15 seconds. The volume in 15 seconds will be used to calculate
maximal minute volume. Each subject will perform one session of deep breathing at each of the body
positions used for the study (relaxed standing, standing with hands clasped overhead, standing with
hands on knees, and sitting with arms supported on a table). The EMG activity will be collected
while the subject is performing the deep breathing to determine the activity in the accessory muscles
of breathing. The four experimental body positions will be assigned randomly with 2 minutes of rest
provided between each session of deep breathing.
e) Describe audiolvisual procedures and proper disposal of tapes.

No audio or visual data will be collected during the study.
f) Describe the qualifications of the individuals conducting all procedures used in the study.

David Reiling is a faculty member in the department of physical therapy. He has performed research
projects with EMG and spirometers in the past. All key personnel have received training on the EMG
equipment. All key personnel have completed IRB training.
g) Describe compensation procedures (payment or class credit for the subjects, etc.).

No compensation will be provided for subjects participating in the study.
Attachments Necessary: Copies of all instruments (such as survey/interview questions, data collection forms completed by
subjects, etc.) must be attached to this proposal.
3. Risk Identification.
a) Clearly describe the anticipated risks to the subject/others including any physical, emotional, and financial risks that might
result from this study.

The potential physical risks associated with this study are minimal. The EMG electrode placement
and analysis is a non-invasive procedure utilized in clinical practice. Minor skin irritation from the
skin preparation and EMG electrodes is possible. The use of a spirometer and assessing breathing

volumes with minute ventilation may lead to dryness and irritation of the mouth, Water will be
available for subjects during the study,
b) Indicate whether there will be a way to link subject responses and/or data sheets to consent forms, and if so, what the
justification is for having that link.

Subject's names will not be used in any reports of the results of this study, Each participant will
complete a written consent form, There will be no association between the written consent form and
the subjects data, At the completion of the study, the research data and the consent forms will be
stored in separate, locked locations in the Department of Physical Therapy for 3 years at which point
the forms and data will be destroyed, Data will only be reported in aggregate form to protect the
confidentiality of all subjects,
c) Provide a description of the data monitoring plan for all research that involves greater than minimal risk.

N/A
d) If the PI will be the lead-investigator for a multi-center stody, or nthe PI's organization will be the lead site in a multicenter Btody, include information about the management of information obtained in multi-site research that might be
relevant to the protection of research participants, such as unanticipated problems involving risks to participants or others,
interim resuits, or protocol modifications,

N/A
4. Subject Protection.
a) Describe precautions you will take to minimize potential risks to the subjects (e.g" sterlle conditions, informing subjects
that some individuals may have strong emotional reactions to the procedures, debriefing, etc,),

Each subject will be provided with their own spirometer mouthpiece. New, clean disposable
electrodes will be utilized for each subject, The possibility of skin irritation will be minimized by
proper skin preparation and subject screening prior to participation, Subjects will be informed of the
placement of electrodes to prevent emotional reactions to concerns about impeding on the subjects
personal space. Investigators will use appropriate draping of the subject during preparation and
placement ofEMG electrodes, The investigator(s) or participant may stop the experiment at any time
if the participant is experiencing discomfort, pain, fatigue, or any other symptoms that may be
detrimental to their health, All subjects will be allowed to terminate their participation in this study at
any time without prejudice.
b) Describe procedures you will implement to protect confidentiality and privacy of participants (such as coding subject dala,
removing ideutifYing information, reporting data in aggregate form, not violating a participants space, not intruding where
one is not welcome or trusted, not observing or recording what people expect not to be public, etc.). Ifparticipants who are
likely to be vulnerable to coercion and undue influence are to be included in the research, define provisions to protect the
privacy and interests of these participants and additional safeguards implemented to protect the rights and welfare of these
participants,

Subject data will not be linked to the consent form in order to protect the confidentiality of the subjects,
Data collection forms and electronic data collection EMG files will be linked together using an alphanumeric code, Data will ouly be reported in aggregate form to assure privacy of the subjects,
Participants will wear appropriate clothing to allow access to the EMG electrode sites, However,
researchers will utilize appropriate draping with sheets and towels during placement of the electrodes
to assure patient comfort and modesty.
c)

Indicate tbat the subject will be provided with a copy of the consent form and how this will be done,

Prior to participation in this study, each subject will read and sign a consent form. Participants in this
study will all be capable of independent decision making and will sign a consent form stating their
understanding and willingness to participate in this study, Participants will be encouraged to ask any
questions regarding the consent form to ensure their understanding of the document, Each participant
will be provided the opportunity to receive a copy of the consent form for their records,
d) Descnoe the protocol regarding record retention, Please indicate that research data from this study and consent forms will
both be retained in separate locked locations for a minimum of three years following the completion of the study,

Describe: I) the storage location of the research data (separate from consent forms and subject personal data)
2) who will have access to the data
3) how the data will be destroyed
4) the storage location of consent forms and personal data (separate from research data)
5) how the consent forms will be destroyed

Participant consent forms and data (collection sheets and electronic files) will be stored separately and
secured in separate locked locations in the Department of Physical Therapy. Only the principal
investigator will have access to both the consent forms and data. Subject data AND CONSENT
FORMS WILL BE RETAINED INRM 1521 IN SEPARATE, LOCKED FILE CABINETS. After a
period of 3 years from the completion of the study, the consent forms and data collection sheets will
be shredded. Electronic data will be deleted or destroyed from all disks/drives.
e) Describe procedures to deal with adverse reactions (refelTals to helping agencies, procednres for dealing with trauma, etc.).

The investigators or participant may stop the experiment at any time if the participant is experiencing
discomfort, pain, abnormal fatigue, or any other symptoms that may be detrimental to their health. If
subjects consent to participate they will be allowed to terminate their participation in this study at any
time without prejudice or jeopardizing any future relationships with the UND Department of Physical
Therapy. Medical treatment will be provided to each subject as needed, including first aid, CPR, and
follow-up care as that provided to a member of the general public in a similar circumstance.
f)

Include an explanation of medical treatment available if injury or adverse reaction occurs and responsibility for costs
involved.

In the event an adverse event occurs during participation in this study, the subject will be prompted to
seek immediate medical attention. All incurred medical expenses will be the responsibility of the
subject or the subject's third-party payer.
m. Benefits of the Stndy
Clearly describe the benefits to the subject and to society resulting from this stody (such as learning experiences, services
received, etc.). Ple••e note: extra credit andlor payment are not benefits and should be listed in the Protocol Description section
under Methodology.

Possible benefits of this study include but are not limited to: 1) furthering the knowledge concerning the
muscle activity used in different breath recovery positions; 2) furthering the knowledge concerning the
breath volume in different recovery positions; 3) further research may be stimulated. Subjects participating
in the study will not receive any compensation nor will they incur any cost associated with this study.
IV. Consent Form
Clearly describe the consent proce:,s below ond be sure to include the following information in your description (Note: Simply
stating 'see attached consent form' is not sufficient The items listed below must be addressed on this fonn.):
I) The person who will conduct the consent interview
2) The person who will provide consent or pennission
3) Any waiting period between infonning the prospective participant and obtaining consent
4) Steps taken to minimize the possibility of coercion or undue influence
5) The longuage to be used by those obtaining consent
6) The language understood by the prospective participant or the legally authorized representative
7) The information to be communicated to the prospective participant or the legally authorized representative

The person to conduct the consent interview will be Dr. David Relling. Consent will be provided by
the subject. Since the study is a one time event with minimal risk, there will be no waiting time between
informing the subject and consent. The investigator will announce the opportunity to participate and post
the appropriate sign while key personnel recruit subjects. Removing the PI from recruitment should
decrease undue influence from the faculty lead study. ENGLISH WILL BE USED FOR OBTAINING
CONSENT AND ALL SUBJECTS MUST BE ABLE TO UNDERSTAND AND UTILIZE ENGLISH.
Information communicated to the prospective participant will include a reading of the study purpose and
what will happen from the informed consent form.
A copy of the consent form must be attached to this proposal If no consent form is to be used, dccument the procedures to be
used to protect humon subjects, and complete the Application for Waiver or Alteration ofInfonned Consent Requirements. Refer

to form IC 70 I-A, Informed Consent Checklist, and make sure that all the required elements ate included. Please note: AU
records attained must be retained for a period of time sufficient to meet federal, state, and local regulations; sponsor
requirements; and organizational policies. The consent form must be written in language that can easily be read by the subject
population and any use of jargon or technicallangnage should be avoided. The consent form should be written at no higher
than an 8th grade reading level, and it is recommended that it be written in the third person (please see the example on the
RD&C website). A two inch by two inch blank space must be left on the bottom of each page of the consent form for the IRB
approval stamp.
Necessary attachments:

1:81 Signed Student Consent to Release of Educational Record Form (students and medical residents only);
1:81 Investigator Letter of Assurance of Compliance; (all researchers)
1:81 Consent form, or Waiver or Alteration oflnformed Consent Requirements (FormIC 702-B)
1:81 Key Personnel Listing
1:81 Surveys, interview questions, etc. (If applicable);

o Printed web screens (if survey is over the Internet); and

1:81 Advertisements (flyer, social media postings, email/letters, etc.).

By signing below, yon are verifying that the information provided in the Human Subject. Review Form and attached
information is accurate and that the pro] ect will be completed as indicated.
Signat
, 412:3/201:5

(principal Investigator)

Date:

(Student Advisor)

Date:

**All students and medica/residents must list a facUlty member as a student advisor on the flrst page of the
application and must have that person sign the application. *"
Requirements for submitting proposals:
Additional information can be found on the IRB website at: htto:l/und.eduireseal'chiresoul'ccs/humall-subjccls/in_lic.'lSllJ:1.
Original, signed proposals and all attachments, along with the necessary number of copies (see below), should be submitted to:
Institutional Review Board, 264 Centennial Drive Stop 7134, Grand Forks, NO 58202-7134, or brought to Room 106, Twamley
Hall.
Required Number of Copies:
• Expedited Review: Submit the signed original and 1 copy of the entire proposal.
• Full Board Review: Submit the signed original and 22 copies of tile entire proposal by the deadline listed on the IRB
website: http://und.edull'esearchiresources/human-subjectslmeeting-schedule.cfin
• Clinical Medical Subcommittee and Fnll Board Review: Submit the signed original and 24 copies of the entire proposal
by the deadline listed on the IRE website: http://und.eduiresearchiresourcesihuman-subjects/meeting-sch,,,Ml:.skill
Prior to receiving IRE approval, researchers must complete the required IRB human subjects' education. Please go to:
http://und.edull'esearch!resources/human.subjects/human-subject-education.cITn
The criteria for determining what category your proposal will be reviewed under is listed on page 3 of the IRB Checklist. Your
reviewer will assign a review category to your proposal. Should your protocol require foll Board review, you will need to
provide additional copies. Further information can be found on the IRB website regarding required copies and IRB review
categories, or you may call the IRE office at 701 7774279.
In cases where the proposed work is part of a proposal to a potential funding source, one copy of the completed proposal to the
funding agency (agreement'contract if there is no proposal) must be attached to the completed Human Subjects Review Form if
the proposal is non-clinical; 5 copies if the proposal is clinical-medical. If the proposed work is being conducted for a
pharmaceutical company, 5 copies of the company's protocol must be provided.

INVESTIGATOR LETTER OF ASSURANCE OF COMPLIANCE
WITH ALL APPLICABLE FEDERAL REGULATIONS FOR THE
PROTECTION OF THE RIGHTS OF HUMAN SUBJECTS

I David P. ReIling, PT. Ph.D.
(Name of Investigator)
agree that, in conducting research under the approval of the University of North Dakota
Institutional Review Board, I will fully comply and assume responsibility for the
enforcement of compliance with all applicable federal regulations and University policies
for the protection of the rights of human subjects engaged in research. Specific
regulations include the Federal Common Rille for Protection of the Rights of Human
Subjects 45 CFR 46. I will also assure compliance to the ethical principles set forth in
the National Commission for the Protection of Human Subjects of Biomedical and
Behavioral Research document, The Belmont Report.
I understand the University's policies concerning research involving human subjects and
agree to the following:
1. Should I wish to make changes in the approved protocol for this project, I will
submit them for review PRIOR to initiating the changes. (A proposal may be
changed without prior IRB approval where necessary to eliminate apparent
immediate hazards to the subjects or others. However, the IRB must be notified in
writing within 72 hours of any change, and IRB review is required at the next
regularly scheduled meeting of the full IRB.)
2. If any problems involving human subjects occur, I will immediately notifY the
Chair of the IRB, or the IRB Coordinator.
3. I will cooperate with the UND IRB by submitting Research Project Review and
Progress Reports in a timely manner.
I understand the failure to do so may resillt in the suspension or termination of proposed
research and possible reporting to federal agencies.

10/1/06

This document identifies the EMG electrode placements for the study titled EMG Activity of Accessory
Muscles of Breathing during Recovery Positions.
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ID #: _2016-._ __
TITLE: EMG Activity of Accessory Muscles of
Breathing during Recovery Positions
Subject Questionnaire and Data Collection
DOB:,_ _ _ _ _ __

Height (in) _______________

Gender:

Weight (lbs)_ _ _ _ _ __

M/F

1) Do you have any difficulty with breathing or physical activity? YESINO
If YES, please explain: _ _ _ _ _ _ _ _ _ _ _ _ _ __
2) Have you had any injuries to your chest or back in the past 3 months? YESINO
If YES, please explain:_ _ _ _ _ _ _ _ _ _ _ _ _ __
3) Have you experienced itching, rash or irritation from bandages or adhesives on
tape? YESINO
If YES, please explain:_________________
POSITION

VCIM

FVC

Standing Arms at
Sides
Standing Hands
on Head
Standing Hands
on Knees
Sitting Arms
Supported

VCin= Vital capacity inspiration
FVC= Forced expiratory vital capacity
FEVl=Forcedexpiratoryvolume after 1 second
FEVl %= FEVl in % of maximal vital capacity
PEF = Maximal expiratory flow (peak floW)
MV= Minute Ventilation

FEVl

FEVl%

PEF

MV
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